Lifeboat Foundation

Invasive round goby fish have impacted fisheries in the Great Lakes and the Finger Lakes by competing with native species and eating the eggs of some species of game fish.

But the camouflaged bottom dwellers can be difficult to find and collect—especially when they first enter a new body of water and their numbers are low and they might be easier to remove.

In a proof-of-principle study, Cornell researchers describe a new technique in which they analyzed environmental DNA—or eDNA—from water samples in Cayuga Lake to gather nuanced information about the presence of these invasive fish.

(MS) has been announced by a collaboration including BioNTech, with a study in mice showing great promise for improving symptoms and stopping disease progression.

ABC News: German authorities accuse Australian man of running DarkMarket, the world’s largest illegal online marketplace.

An Australian is allegedly at the centre of what German authorities believe was the biggest illegal marketplace on the darknet where more than $220 million was transacted over sales of drugs, forged money, SIM cards and bogus credit cards.

A major risk of being hospitalised is catching a bacterial infection.

Hospitals, especially areas including intensive care units and surgical wards, are teeming with bacteria, some of which are resistant to antibiotics —they are infamously known as ‘superbugs’.

Superbug infections are difficult and expensive to treat, and can often lead to dire consequences for the patient.

Circa 2017 o.o

The trial plans to inject stem cells into the spinal cords of people declared clinically brain dead, with the ultimate goal of restarting brain activity.

Researchers have come up with a way to electronically write data into the DNA of living bacteria, a storage option unlikely to go obsolete any time soon.

New method enables electronic conversion of data into DNA.

Summary: 20% of glioblastoma brain cancers are fueled by overactive mitochondria. Researchers say these cases may be treatable by drugs currently under trial.

Source: Columbia University.

A new study has found that up to 20% of glioblastomas–an aggressive brain cancer–are fueled by overactive mitochondria and may be treatable with drugs currently in clinical trials.

UC San Francisco scientists have discovered a new way to control the immune system’s “natural killer” (NK) cells, a finding with implications for novel cell therapies and tissue implants that can evade immune rejection. The findings could also be used to enhance the ability of cancer immunotherapies to detect and destroy lurking tumors.

The study, published today (January 82021) in the Journal of Experimental Medicine, addresses a major challenge for the field of regenerative medicine, said lead author Tobias Deuse, MD, the Julien I.E. Hoffman, MD, Endowed Chair in Cardiac Surgery in the UCSF Department of Surgery.

“As a cardiac surgeon, I would love to put myself out of business by being able to implant healthy cardiac cells to repair heart disease,” said Deuse, who is interim chair and director of minimally invasive cardiac surgery in the Division of Adult Cardiothoracic Surgery. “And there are tremendous hopes to one day have the ability to implant insulin-producing cells in patients with diabetes or to inject cancer patients with immune cells engineered to seek and destroy tumors. The major obstacle is how to do this in a way that avoids immediate rejection by the immune system.”

Biologists have used CRISPR gene editing to store information inside DNA in living bacterial cells, which could become a storage medium of the future.